Pulmnoeze contains Budesonide 0.5 mg in a nebuliser suspension. Budesonide is an inhaled corticosteroid; as an active ingredient, it acts through glucocorticoid receptors to reduce airway inflammation. It is used in maintenance therapy for asthma and is not intended to replace immediate-relief treatment during an acute episode. Use should follow clinical assessment and the product’s prescribing information. The supplied pack format is 4 × 5 × 2 mL; confirm product details and appropriate use with a healthcare professional.
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about Pulmnoeze for professional use.